CRYSTALLINE FORM OF PYRROLE AMIDE COMPOUND, PREPARATION METHOD THEREFOR AND USE THEREOF

Provided are a crystalline form of a pyrrole amide compound, a preparation method therefor and a use thereof, and also provided is a pharmaceutical composition comprising the crystalline form. In particular, the crystalline form or the pharmaceutical composition can be used to treat and prevent dise...

Full description

Saved in:
Bibliographic Details
Main Authors ZHANG, YINGXUN, CHEN, LIANG, ZONG, QIAO, WANG, JIANCHENG, ZUO, YINGLIN, WANG, XIAOJUN
Format Patent
LanguageEnglish
French
Published 06.10.2022
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Provided are a crystalline form of a pyrrole amide compound, a preparation method therefor and a use thereof, and also provided is a pharmaceutical composition comprising the crystalline form. In particular, the crystalline form or the pharmaceutical composition can be used to treat and prevent diseases such as hyperaldosteronism, diabetic nephropathy, hypertension, heart failure (comprising chronic heart failure, etc.), sequelae of myocardial infarction, liver cirrhosis, renal failure, and stroke. L'invention concerne une forme cristalline d'un composé de pyrrole amide, son procédé de préparation et son utilisation, ainsi qu'une composition pharmaceutique comprenant la forme cristalline. En particulier, la forme cristalline ou la composition pharmaceutique peut être utilisée pour traiter et prévenir des maladies telles que l'hyperaldostéronisme, la néphropathie diabétique, l'hypertension, l'insuffisance cardiaque (comprenant une insuffisance cardiaque chronique, etc.), des séquelles d'infarctus du myocarde, une cirrhose du foie, une insuffisance rénale et un accident vasculaire cérébral.
Bibliography:Application Number: CA20223213094